March 27, 2025
TOPLINE: The incidence of serious adverse events did not differ significantly between combo therapy and monotherapy in patients with immune-mediated inflammatory diseases. However, specific combinations such […]
March 25, 2025
Ageism in healthcare not only is frustrating and demoralizing for older patients but also negatively affects care. In rheumatology, patients with rheumatoid arthritis (RA) diagnosed later […]
March 24, 2025
TOPLINE: Belimumab combined with standard therapy demonstrated significant improvements in mucocutaneous symptoms in patients with systemic lupus erythematosus (SLE) compared with placebo with standard therapy, with […]
March 21, 2025
TOPLINE: Sustained clinical remission for at least 3 years in patients with systemic lupus erythematosus (SLE) and active lupus nephritis significantly reduced the probability of developing […]
March 20, 2025
For juvenile idiopathic arthritis (JIA), 2024 was marked by both successes and heightened controversy. There were new US Food and Drug Administration (FDA) warnings for DRESS […]
March 20, 2025
TOPLINE: The recombinant zoster vaccine (RZV) Shingrix demonstrated effectiveness in preventing herpes zoster (HZ) and postherpetic neuralgia among adults aged 50 years or older with rheumatoid […]
March 19, 2025
TOPLINE: A meta-analysis of 16 observational studies found no significant association between vaccination exposure and risk for rheumatoid arthritis (RA). Short-term follow-up data (< 1 year) […]
March 18, 2025
For people with complex chronic diseases such as long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and dysautonomia, a clinician’s inadvertently hurtful language can compound suffering and […]
March 18, 2025
Hip and knee replacements are increasingly predictable and durable, with a better patient experience and a “declining revision burden,” as demand increases from both an aging […]